Microglial A20 Protects the Brain from CD8 T-Cell-Mediated Immunopathology Graphical Abstract Highlights d A20-deficient microglia acquire an inflammatory signature seen in viral infections d CD8 + T cells infiltrate the CNS when microglia lack A20 d Infiltrating CD8 + T cells are responsible for phenotypic changes in microglia and neurons d Cortical neurons are hyperactive and have an increased number of synaptic terminals
INTRODUCTION
A20 is a key negative regulator of canonical nuclear factor kB (NF-kB) signaling, which mediates its effects via ubiquitin modification of different proteins involved at various levels of the signaling cascade, thereby regulating the pro-inflammatory response induced downstream of NF-kB activation (Baltimore, 2011) . Mice fully deficient for A20 die early due to multi-organ inflammation and severe weight loss, partly due to an inability to regulate tumor necrosis factor (TNF)-induced NF-kB signaling (Lee et al., 2000) . Therefore, to better understand the role of A20 in inflammation, cell-type-specific deletion of the molecule is necessary. Indeed, aspects of human diseases associated with mutations in TNFAIP3 can be mimicked by A20 deletion in specific cells (Ma and Malynn, 2012) . The role of A20 in peripheral immune cells has been well investigated, but less is known about its role in the central nervous system (CNS) . Interestingly, among all CNS-resident cells, microglia express the highest levels of A20 (Zhang et al., 2014) .
Microglia are the resident immune cells of the CNS. Under normal conditions, they are highly ramified, and their processes are constantly moving and monitoring their surroundings (Nimmerjahn et al., 2005) ; thus, they are perfectly poised to rapidly respond to any changes in the homeostasis of the CNS. In addition, they play crucial roles in synapse formation and pruning (Miyamoto et al., 2016; Paolicelli et al., 2011; Schafer et al., 2012) , promoting myelination and remyelination (Miron, 2017) , and regulating neuronal activity (Li et al., 2012; Wake et al., 2009) . Therefore, considering the importance of microglia in the normal functioning of the CNS, we were interested to determine the role of A20 in these cells.
To investigate the role of A20 in microglia, we crossed tamoxifen (TAM)-inducible Cx3cr1-Cre ERT2/+ mice to A20 fl/fl mice. This system allows microglia-specific deletion of the target gene, as other myeloid cells are replaced with time (Yona et al., 2013) . Upon deletion of A20 in microglia, we found a rapid induction of neuroinflammation, characterized by the infiltration of CD8 + T cells and the upregulation of pro-inflammatory molecules by microglia in these A20-deficient (A20 Dmg ) mice. Strikingly, both A20-deficient microglia and infiltrating CD8 + T cells acquire a gene expression signature and upregulate genes involved in responding to viral infections. Furthermore, microglial numbers were increased in all regions of the brain examined, associated with alterations in morphology toward decreased complexity.
Furthermore, the deletion of A20 in microglia affected the cortical neurons. Pyramidal neurons displayed altered AMPAreceptor mediated spontaneous excitatory currents associated with a decrease in the density of parvalbumin (PV) + inhibitory interneurons and an increase in the number of excitatory presynaptic terminals in the cortex. Interestingly, these changes in microglia number and morphology were not observed in A20 Dmg mice on the Rag1 À/À background, which do not have (C) Differential expression of Tnfa, Il1b, Ccl2, and Ccl3 by cultured microglia with and without LPS stimulation. (D) Immunofluorescence staining for microglia using Iba1 (green) with DAPI (blue) in cortex, hippocampus, and striatum in A20 Dmg mice and littermate controls 2 weeks after TAM treatment. Scale bar, 100 mm. mature B or T cells. Importantly, increased numbers of excitatory terminals were not observed in the absence of functional RAG enzymes. In summary, our data suggest that microglial A20 is a gatekeeper of CNS homeostasis, and deletion of A20 in microglia imitates the scenario seen following CNS viral infection.
RESULTS

A20-Deficient Microglia Upregulate Pro-inflammatory Molecules
We crossed the A20 fl/fl mice to the CX3CR1-Cre ERT2 mice and injected A20 fl/fl and A20 fl/fl CX3CR1-Cre ERT2/+ pups with TAM at postnatal day 14 (P14) and P16 by subcutaneous administration, resulting in the translocation of the Cre recombinase to the nucleus of CX3CR1 + myeloid cells and subsequent deletion of A20 in these cells. After 6 weeks, we confirmed the deletion of the A20-coding gene (Tnfaip3) in microglia isolated from A20deficient mice, termed here A20 Dmg , by RT-PCR ( Figure 1A ). We also observed spontaneous upregulation of Tnfa and a tendency to upregulate Il6, Ccl2, and Ccl3, but not Il1b, in the microglia of the A20 Dmg mice ( Figure 1B) , indicating an inflammatory environment in these mice. Since microglia isolation can lead to stress, which alters the RNA expression profile, we cultured and rested microglia from the A20 Dmg and TAM-treated control mice before analysis. We also examined whether A20deficient microglia were more sensitive to inflammatory stimuli by adding lipopolysaccharide (LPS). Mirroring the ex vivo data, resting microglia from A20 Dmg mice spontaneously upregulated Tnfa expression when compared to control microglia and responded more to LPS stimulation ( Figure 1C ). Furthermore, Il-1b and Ccl3 expression levels were increased after resting and without stimulation ( Figure 1C ), confirming an intrinsic inflammatory profile in A20-deficient microglia.
We previously showed that deleting A20 in B cells not only induced a hyperactive phenotype but also enhanced cell proliferation upon activation (Hö velmeyer et al., 2011) . Therefore, we expected that the deletion of A20 in microglia, which induces a pro-inflammatory environment in the CNS, would affect their steady state in a similar way. Indeed, when we then analyzed the microglia numbers in the A20 Dmg mice, we found significantly more Iba1 + microglia in the cortex, hippocampus, and striatum of these mice compared to control animals (Figures 1D and 1E) . Bromodeoxyuridine (BrdU) feeding for 1 week after TAM administration followed by immunostaining showed that microglia in the cortex of A20 Dmg mice proliferated during this time ( Figure 1F ). Small clusters of microglia with BrdU labeling were also identified in the cortex ( Figure 1G ), while minimal BrdU labeling was seen in control mice. While analyzing the number of microglia, we also noticed that the morphology of the microglia in the A20 Dmg mice seemed to be altered compared to those of the control mice. We thus performed 3D reconstruction of microglia imaged from the upper layers (layers II/III) of the cortex. This analysis revealed large, well-branched microglia in control mice with a small soma, whereas microglia from A20 Dmg brains were less branched, approaching a more amoeboid-like appearance ( Figure 1H ). Sholl analysis on the reconstructed cells quantified and confirmed a significantly decreased branching complexity of A20-deficient microglia ( Figure 1I ). To determine whether the morphological changes were due to the increased proliferation of microglia in A20 Dmg mice, we analyzed the morphology of BrdU + and BrdU À microglia from A20 Dmg mice. Sholl analysis revealed no differences in the cell morphology between BrdU + and BrdU À A20-deficient microglia (Figures S1A and S1B). Therefore, the change in microglial morphology is due to A20 deficiency rather than increased proliferation and secondary alteration in morphology.
Spontaneous Neuroinflammation in Steady State of A20 Dmg Mice
Next, we analyzed cells isolated from the whole CNS of the A20 Dmg mice using flow cytometry to determine whether and how the deletion of A20 in microglia affects other cells. Interestingly, we noticed an unusually large population of CD45 hi CD11b À cells present in the CNS of A20 Dmg mice, but not in the control animals (Figures 2A and 2B ). Further analysis showed that this population consisted primarily of T cell receptor (TCR) b + CD8 + T cells, in addition to a smaller population of CD4 + T cells (Figures 2C and 2D) . This infiltration was specific to the CNS; analysis of immune cells in the lung and gut, which also have A20-deficient CX3Cr1 + cells at an early time point after TAM treatment, showed no such infiltration (Figures S2A and S2B) . To determine when T cells begin to infiltrate the CNS of these mice, we analyzed the CNS from 1 week up to 1 year after TAM administration. We found that T cells rapidly infiltrate the CNS and are already present from 1 week after the last TAM injection, and they continue to increase in number until the 2-week time point, after which numbers decreased, although they stayed higher than controls even up to 1 year after microglial A20 deletion ( Figure 2E ). We also confirmed that this 2-week peak was not due to the young age of the mice at the point of TAM administration (i.e., P14) by administering TAM to 8-week-old mice and confirming high CD8 + T cell infiltration into the CNS 2 weeks after TAM administration ( Figure S2C ).
The analysis of the infiltrating CD8 + T cells showed them to be effector cells that express high levels of CD44 ( Figure 2F ), and significantly more of them express CD127 when they first start infiltrating the CNS ( Figure 2G ). Over time, the expression levels of CD127 decreased ( Figure 2G ), which, in viral models, is associated with the expansion of effector T cell populations and an (E) Quantification of microglia numbers 2 weeks after TAM treatment in cortex, hippocampus, and striatum. (F) Staining for Iba1 (green) and BrdU (magenta) in the cortex of control and A20 Dmg mice. (G) Zoomed image of a BrdU + microglia cluster in the cortex of A20 Dmg mouse. (H) Representative snapshots from A20 Dmg mice and littermate controls after 3D reconstruction of microglia imaged from layers II/III of the cortex. (I) Sholl analysis of reconstructed microglia. N = 4 mice, n = 13 cells for controls; N = 5, n = 15 for A20 Dmg mice. Data in bar graphs are represented as mean ± SD. Sholl analysis is shown with mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, Mann-Whitney test (A-C and E) and two-way ANOVA (I).
increased susceptibility to apoptosis (Bachmann et al., 2005) . In contrast, PD-1 expression increased with time ( Figure 2H ), implying exhaustion of these cells. However, upon stimulation, a greater proportion of the infiltrating CD8 + T cells from A20 Dmg animals produced interferon g (IFN-g) compared to controls (Figures 2I and 2J) , indicating that the infiltrating T cells are still responsive rather than exhausted. Interestingly, analysis of the TCR V-beta (Vb) repertoire of infiltrating CD8 + T cells by flow cytometry at the 2-week time point shows a polyclonal expansion of CD8 + T cells expressing TCR Vb 2, 7, 8.1/8.2, and 13 specifically in the brain compared to the TCR Vb repertoire found in the spleens of the same or control mice, which we confirmed in two independent experiments ( Figure S2D ). Lastly, we performed immunostaining on paraffin-embedded sections to determine the localization of the infiltrating CD8 + T cells in the CNS of A20 Dmg mice. We found CD8 + T cells not only in the meninges (pia) and choroid plexus ( Figures S2E and S2F ) but also within the parenchyma, infiltrating along the corpus callosum and into the cortex ( Figure 2K ).
A20-Deficient Microglia Display a Highly Inflammatory Signature
We found that deletion of A20 in microglia led to the invasion of the CNS by CD8 + T cells. Therefore, we decided to investigate what alterations were induced by the A20 deletion in microglia in an attempt to understand how microglia could be mediating the immunological changes observed. To do this, we crossed the mice with eYFP (enhanced yellow fluorescent protein)-reporter mice and isolated eYFP-expressing microglia from control (A20 fl/wt eYFP +/À CX3CR1Cre ERT2/+ ) and eYFP +/À A20 Dmg (E) Timeline analysis of cell infiltrates in the brain for infiltrates after TAM administration. (F-J) Expression of CD44 (F), CD127 (G), PD-1 (H), and IFN-g (I and J) in infiltrating CD8 + T cells isolated from A20 Dmg mice (K) Shows CD8 + T cells (green and arrowheads) in the parenchyma of the brain along the corpus callosum (CC) and in the cortex (CX) of A20 Dmg mice. Scale bars 50 mm and 20 mm (right panel, zoom). Data are shown as mean ± SD. *p < 0.05, **p < 0.01, and ***p < 0.001, Mann-Whitney test (B, E, I, and J) and two-way ANOVA (G and H). mice 2 weeks after TAM injection and performed RNA sequencing (RNA-seq). Principal-component analysis of the top 5,000 expressed genes shows differential clustering of the control and the A20 Dmg samples ( Figure S3A ). An MA plot of all detected genes shows many differentially expressed genes (red) in the A20-deficient microglia compared to controls ( Figure S3B ). We focused our analysis on pathways that were altered and performed a gene set enrichment analysis (GSEA). This, along with compiled modules from Gene Ontology (GO) , revealed an upregulation of gene signatures related to antiviral responses, cytokine production, and response to IFN-g in the microglia of A20 Dmg mice ( Figure 3A ; false discovery rate [FDR] < 0.25, normalized enrichment score [NES] > 1.5). We also found that A20-deficient microglia share signature genes with neurodegenerative disease-associated microglia (DAM; Keren-Shaul et al., 2017) but downregulate genes typically associated with homeostatic resting microglia ( Figure 3B ), further underlining the importance of A20 expression in microglia to maintain homeostasis in the CNS. Interestingly, we also found downregulation of genes involved in synaptic assembly ( Figure 3C ). Next, we generated an Enrichment Map network of the enriched GO terms derived from the GSEA of A20 Dmg mice relative to A20 control mice. The network analysis reveals an upregulation of densely connected enriched gene sets with roles in response to interferons and chemotaxis, defense response against viruses and bacteria, and the regulation of adaptive immunity ( Figure 3D ). Furthermore, we found that microglia from A20 Dmg mice upregulate many genes associated with the response to viruses (Figures 3E and 3F) . We could also establish that A20-deficient microglia express signature genes that are highly upregulated by activated microglia in a model of T-cell-mediated encephalitis (viral dé jà vu model; Merkler et al., 2006) (Figure 3G ). Overall, microglia lacking A20 develop an antiviral gene expression signature and disrupt the homeostasis of the CNS, leading to the infiltration of CD8 T cells. 
CNS-Infiltrating CD8 T Cells in A20 Dmg Mice Downregulate Inhibitory Molecules
We then wanted to better understand whether and how the CNS-infiltrating CD8 T cells in A20 Dmg mice alter their expression profile. Using fluorescence-activated cell sorting (FACS)isolated CD8 T cells from the brains of control and A20 Dmg mice, we performed single cell sequencing using the BD Rhapsody Immune Response Panel. We sequenced 260 CD8 + T cells from control brains and 440 cells from A20 Dmg mice. Principal-component analysis shows that the CD8 T cells from control mice cluster into two groups and that CNS-infiltrating CD8 T cells from A20 Dmg mice cluster together ( Figure 4A ). Examination of all upregulated genes in CD8 T cells from A20 Dmg mice compared to controls shows an increase in the expression of genes related to a (chronic) viral response ( Figures 4B and 4C ). CD8 T cells from A20-deficient mice upregulate genes such as Pdcd1, Lag3, Tigit, and Entpd1, which have all been shown to be associated with chronic viral infections. Furthermore, the IFNg-inducible genes Cxcl10, Oas2, and Stat1 are also significantly upregulated by CNS-infiltrating CD8 T cells in A20 Dmg mice ( Figure 4C ). Interestingly, CNSpatrolling CD8 T cells in control animals express inhibitory genes, which are downregulated in the CNS-infiltrating CD8 T cells of A20 Dmg mice ( Figures 4D and 4E ). The inhibitory molecules Klrc1, Klra1, Klra3, and Klra7 are molecules typically expressed by natural killer (NK) cells. Interestingly, the upregulation of viral-signature genes is specific to CNS-infiltrating CD8 + T cells. Analysis of splenic CD8 + T cells by qPCR for selected genes found in Figure 4C shows no similar upregulation of the genes for the transcription factors Stat1 and Irf7 (Figure 4F ), the chemokines Ccl3 and Xcl1 ( Figure 4G ), or the activation/exhaustion markers PD-1, Lag3, and Ctla4 (Figure 4H ). This indicates that the viral response signature found in CNS-infiltrating CD8 + T cells is a response localized specifically to the CNS. Overall, we discovered that steady-state CNS-patrolling CD8 + T cells in non-inflammatory conditions show similarities to NK T cells through the expression of inhibitory genes. In A20 Dmg mice, on the other hand, CNS-infiltrating CD8 + T cells are activated and upregulate genes required for a viral response, similar to what we observed in the microglia.
Altered AMPA-Receptor-Mediated Spontaneous Excitatory Postsynaptic Currents (sEPSCs) in Cortical Pyramidal Neurons of A20 Dmg Mice Considering that microglia are heavily involved in forming neuronal networks through their role in synaptic pruning and therefore closely interact with neurons (Miyamoto et al., 2016; Wake et al., 2009) , we wanted to examine any functional consequences of microglial activation and CD8 infiltration on neurons in A20 Dmg mice. Furthermore, RNA-seq of A20-deficient microglia showed a differential expression of genes involved in synapse assembly. Interestingly, during our analysis of microglial morphology, we observed that A20-deficient microglia seemed to be in close contact with neurons as compared to the controls (Figure 5A, arrowheads) . Since increased microglia-neuron interactions have been described in inflammatory states, we then imaged microglia and neuronal soma (labeled with Iba1 and NeuN, respectively) from the upper cortical layers to better classify and quantify the microglial-neuronal interactions. We categorized the interactions between microglia and neurons as follows: microglial soma in close contact with neuronal soma with their processes either further enwrapping the neuron (category I) or not (category II), close contact of only microglial processes with neuronal soma (category III), and microglia not in close contact with neurons ( Figure 5B ). Quantification showed that significantly more A20-deficient microglia enwrapped the neuronal soma with their processes compared to controls (Figure 5B , category I).
Close interactions between microglia and neurons have been shown to be altered in states of inflammation. These interactions lead to either neuroprotection or damage, although the conditions leading to each outcome are not well understood (Gomes-Leal, 2012 ). On the one hand, it has been shown that microglia in zebrafish react to highly active neurons by increasing contact to neuronal soma (Li et al., 2012) , and in a model of traumatic brain injury, microglia closely interacting with neurons remove inhibitory presynaptic terminals, which leads to enhanced synchronized firing and reduced apoptosis of neurons . On the other hand, a recent publication showing increased microglia-neuron contact in viral infections describes how this interaction can lead to the development of pathology (Di Liberto et al., 2018) . Therefore, to investigate possible alterations in the neurons and neuronal populations in A20 Dmg mice, we first examined the PV-expressing interneuron population of the cortex 2 weeks after TAM administration. We counted the number of PV + interneurons present in the cortex (excluding layer I, sagittal sections) as outlined in (Figure 5C ). Upon quantification, we found a significantly decreased number of PV + interneurons in the cortex of A20 Dmg mice as compared to the control animals ( Figures 5C and 5D ).
To determine whether any regional differences were present, we then performed an unbiased analysis on coronal sections, dividing the cortex into medial and lateral areas, containing the motor and somatosensory cortices, respectively. While this analysis revealed no differences in the whole cortex (data not shown), we found a significant reduction in the density of PV + interneurons in the medial area of the cortex, while no differences were present in the lateral regions ( Figure 5E ).
To determine whether the changes in microglial morphology, increased microglia contact to neurons, and decreased numbers of PV + cortical neurons in A20-deficient mice had a functional impact, we analyzed AMPA-receptor-mediated sEPSCs at single pyramidal neurons from layer III in acute cortical brain slices. sEPSCs were pharmacologically isolated and recorded at a holding potential of À80 mV ( Figure 5F ). We found that the mean frequency of sEPSCs was significantly increased in cells of A20-deficient mice (10.06 ± 0.5 Hz, n = 13) as compared to controls (7.65 ± 0.6 Hz, n = 10, **p < 0.01) ( Figure 5G ). Moreover, a significant difference in the mean sEPSCs amplitude was evident between A20-deficient mice (8.34 ± 0.7, n = 13) and control mice (6.36 ± 0.4, *p < 0.05) ( Figure 5H ). However, the comparison of the rise and decay time as well as the rise slope did not disclose any differences between the two groups ( Figures  5I-5K ). The increased frequency suggested alterations at the presynaptic side; therefore, we analyzed different types of synaptic terminals in layer III of the cortex. A general presynaptic marker, synaptophysin, showed no differences between A20 Dmg mice and control mice in the numbers of the synapses and the perisomatic terminals ( Figure 5L ; data not shown). Similar findings were obtained for GAD65/67 + terminals, indicating no changes for GABAergic terminals ( Figure 5M ; data not shown). On the other hand, staining specifically for excitatory presynaptic terminals with VGLUT1 revealed a significant increase in the number of VGLUT1 + terminals ( Figure 5N ). However, there were no differences in the number of excitatory postsynaptic terminals identified by Homer1 staining ( Figure 5O ). The increased numbers of VGLUT1 + terminals in the cortex of A20 Dmg mice correlate with the alterations in the sEPSCs, namely the increased frequency. Overall, our findings suggest that the activation state of microglia and the observed neuroinflammation have major consequences for neuronal populations and activity in A20 Dmg mice, leading to an increased frequency and amplitude of spontaneous glutamatergic currents at pyramidal neurons.
Alterations in Microglia and Neurons Depend on Infiltrating CD8 + T Cells
Interestingly, we observed several instances of microglia closely interacting with CD8 + T cells ( Figures 6A and S4 ), suggesting an active response by the microglia. Therefore, to determine whether the infiltration of CD8 + T cells influences the microglial phenotype, we crossed A20 Dmg mice to mice lacking the Rag1 gene and therefore mature T and B cells. Examination of the microglia from the brains of the Rag ko A20 Dmg mice compared to the Rag ko controls (Rag ko A20 fl/fl ) showed no differences in the numbers of cortical microglia ( Figures 6B and 6C ). In further contrast to the differences we observed between control and A20 Dmg mice, the microglia morphology was not altered between Rag ko controls (Rag ko A20 fl/fl ) and Rag ko A20 Dmg mice, as analyzed using 3D reconstruction and Sholl analysis ( Figures  6D and 6E ). We then quantified numbers of PV-expressing interneurons of the cortex and again found no differences between control and A20-deficient animals on the Rag ko background (Figure 6F) . We also performed an unbiased analysis to quantify PV + interneurons from identical regions of the brain as mentioned previously. There were no differences found in the whole cortex with this analysis, nor was there any difference between genotypes when independently analyzing medial ( Figure 6F , right graph) and lateral regions (data not shown). We then examined the synaptic terminals in the cortex of Rag-deficient animals and found no differences in the numbers of synaptic terminals positive for synaptophysin ( Figures 6G and 6H ), GAD65/67 ( Figures 6I and 6J ), or VGLUT1 ( Figures 6K and 6L ) or for Homer 1 (Figures 6M and 6N ). Next, since Rag1-deficient mice lack all T cells, in addition to B cells, we depleted CD8 T cells over 3 weeks in control and A20 Dmg mice to isolate the influence of infiltrating CD8 T cells. After confirming that circulating CD8 T cells were depleted ( Figures S5A-S5C) , we analyzed the brains for infiltrates. While the A20 Dmg brains showed no significant increase in the proportion of infiltrating cells ( Figures S5D and  S5G) , the number of cells was still increased in A20-deficient brains. Infiltrates had similar proportions of T cells ( Figures S5E  and S5H) , and further analysis showed that infiltrating CD8 + T cells were effectively eliminated ( Figures S5F and S5I) , although an increased number of CD4 + T cells were still present in the brains of A20 Dmg mice (data not shown). Analysis of microglial number and morphology showed no differences between control and A20 Dmg brains when CD8 T cells were depleted (Figures 6O-6R) . Taken together, the data from Rag-deficient mice and CD8 depletion show that the alterations in morphology and numbers of microglia and the associated alterations in neurons found in the A20 Dmg mice are not intrinsic but rather an active response to the presence of T cells and/or cytokines produced by these cells.
In summary, upon A20 deletion, microglia develop an inflammatory profile, characterized by the upregulation of chemokines, cytokines, and components involved in the antiviral immune response. This is further accompanied by an increase in microglial numbers and a change in morphology. However, and most strikingly, these changes are not intrinsic to the deletion of A20 in microglia but rather stem from a response to the presence of T cells in the CNS, as the alterations we observed in A20-deficient microglia do not occur in Rag ko A20 Dmg mice.
DISCUSSION
After deleting A20 in microglia, a sequence of events is initiated, leading to the development of neuroinflammation and affecting the homeostasis of the CNS, characterized by an inflammatory environment and altered microglia morphology, in addition to altered AMPA-mediated currents associated with increased numbers of excitatory synapses in the cortex. Interestingly, a deficiency of the fractalkine receptor, as we have in our A20 Dmg mice, usually leads to a transient decrease in microglial numbers as well as weaker sEPSC amplitudes. However, these phenotypes are the opposite of what we find in the brains of our A20 Dmg mice, and it could be that under a different myeloid-specific Cre, we would see a stronger effect as a result of the A20 deletion.
A recent study also describing A20-deficient microglia did not report a similar effect of the A20 deletion on microglia. In contrast to the decreased complexity we observed, the microglia in their animals were more branched compared to controls (Voet et al., 2018) , although A20-deficient mice still had increased numbers of microglia. Furthermore, they did not report the presence of infiltrating T cells (Voet et al., 2018) , which, in our case, drives the alterations observed in the brains of A20-deficient mice. As the two mutations were very similar in nature, we do not really have an explanation for these differences in results, apart from possible differences in the time of analysis (4 weeks after TAM versus 2 weeks in our study) or differences in the microbiome present in the two different animal facilities. It is also probable that the regions analyzed in the Voet et al. study were not the same between mice; there is no mention of which regions of the brain were used to analyze microglial morphology, for instance, whereas we analyzed microglia from layers II/III of the cortex. As microglia in steady state are not a homogeneous population, it is possible that the differences between the two studies regarding microglial branching arise from this. There is also always the possibility their mice did have infiltrating T cells, but they did not notice this in the course of their analysis. We observed this primarily through flow cytometry analysis in steady state, which is present in the Voet et al. study, but FACS plots are not shown, so we really cannot draw any conclusions.
In our model, peripheral Cx3Cr1-expressing myeloid cells are also deficient for A20 for a short time following TAM injection. As the lack of A20 in peripheral immune cells has previously been shown to have consequences mimicking autoimmune diseases, it is possible that during this time, factors are released that can trigger an inflammatory reaction in microglia, leading to the (legend continued on next page) production of chemokines attracting immune cells to the CNS. While we could not identify a specific signal or signals attracting specifically T cells to infiltrate the CNS, what is interesting to note is that not only IFN-b, but also IFN-g, the main cytokine produced by the infiltrating CD8 + T cells in A20-deficient mice, can enhance NF-kB signaling in myeloid cells and even sensitize the pathway to weak activating signals (Mitchell et al., 2019) . It could be that as CD8 + T cells begin to enter the CNS, they produce IFN-g, which further enhances NF-kB signaling in microglia, leading to increased production of inflammatory molecules associated to a viral response, further enhancing the entry and activation of CD8 + T cells. This is partly supported by our experiments with A20 Dmg mice on the Rag1 À/À background and the CD8-depletion experiments. Without infiltrating CD8 + T cells in the CNS, there are no alterations in microglial morphology or number, indicating an active role played by CD8 + T cells in affecting microglial activation, possibly through the production of IFN-g.
Also of interest, normal patrolling CD8 + T cells found in naive animals express inhibitory molecules, which are downregulated by the infiltrating cells in A20 Dmg mice. It would be of interest to further characterize the expression of inhibitory molecules by CNS-patrolling CD8 + T cells in steady state to better understand their role and how they change and respond to insult.
Most strikingly, A20-deficient microglia upregulate signature genes associated with the response to viral infections, including IFN-b, which has been shown to require NF-kB to be induced (Bartlett et al., 2012) , and various IFN-inducible genes. However, the non-canonical NF-kB pathway plays more of a role in the negative regulation of IFN-b (Jin et al., 2014) , and thus, the upregulation of IFN and IFN-inducible genes was not necessarily expected. However, what must be considered is that the infiltrating CD8 + T cells in A20 Dmg mice also strongly upregulate molecules usually seen in viral infections. We would need to do further experiments to determine whether in the absence of CD8 + T cells microglia still upregulate genes related to IFN-inducible genes or the IFN pathway. It could be due to the interaction with CD8 + T cells that microglia develop this gene signature secondary to the deletion of A20, rather than a direct consequence of the loss of A20. However, it is also of interest to note that IFNs are produced in response to viral infections, and a dysregulation in IFN production in the CNS can lead to neuroinflammation and neurological damage (Akwa et al., 1998; Campbell et al., 1999) . Astrocytic overexpression of IFN-a led to hyperexcitability of CA1 hippocampal neurons, as well as a loss of PV-containing interneurons (Campbell et al., 1999) , similar to what we observe in the cortex of our A20-deficient mice. Overexpression also led to the infiltration of lymphocytes, in particular CD4 + T cells, in addition to CD8 + T cells and B cells (Akwa et al., 1998) . In considering an antiviral response, it could be that a focus on IFN signaling and the effects of IFN on the CNS is required to better understand the overall sequence of events in the CNS of A20-deficient mice and look further into the differentially regulated genes in microglia involved in neurodegenerative disease.
It should be noted that NF-kB signaling in microglia under steady-state conditions is active and plays a role in the regulation of synaptic plasticity and neuronal excitability (Kyrargyri et al., 2015) . Interestingly, post-mortem and imaging studies of brains from individuals with schizophrenia describe elevated levels of microglia activation (Kenk et al., 2015; Rao et al., 2013) , which is associated with an increased expression of pro-inflammatory molecules (Fillman et al., 2013; Rao et al., 2013) . Moreover, this activated profile of microglia has been hypothesized to contribute to the deficits in cortical networks observed in patients with schizophrenia (reviewed by Volk, 2017) . Also of interest, autoimmune diseases that have been associated with SNPs in TNFAIP3, such as rheumatoid arthritis, systemic lupus erythematosus, and psoriasis, are also associated with neurological and psychiatric comorbidities (Amanat et al., 2018; Appenzeller et al., 2006; Joaquim and Appenzeller, 2015) . Further considering that CNS viral infections can lead to a number of neurological problems such as epilepsy, which can be modeled by infection with Theiler's murine encephalomyelitis virus (Cusick et al., 2013) , and that the release of inflammatory cytokines during viral infection early in development has been associated with the development of autism or schizophrenia in some individuals (Libbey et al., 2005; Mahic et al., 2017; Pearce, 2001) , altogether, this could indicate a role for microglia and overactivation of the NF-kB pathway in the development of neurological pathology.
Future studies with the A20 Dmg mice will need to include an indepth behavioral analysis to determine the full range of functional consequences of the altered neuronal activity in A20 Dmg mice and further elucidate the connection between an induced viral response in the CNS and the subsequent development of neuronal pathology. It would also be interesting to see how the A20 Dmg mice respond to (non-neurotropic) viral infections whether these mice in the end do develop a neurological pathology.
All in all, the deletion of A20 in microglia provides us with a powerful tool to isolate the role of inflammatory microglia in the development of pathology and neuropsychiatric disease, in addition to outlining the critical role A20 and NF-kB signaling play in maintaining CNS homeostasis through its function in microglia.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
All mice used were on the C57BL/6J background and housed under specific-pathogen-free conditions. Cx3cr1-Cre ERT2/+ mice 12 were bred to A20 fl/fl mice. A20 fl/fl Cx3cr1-Cre ERT2/+ (A20 Dmg ) mice were further crossed to the Rag 1 À/À background. For sequencing experiments, A20 fl/fl Cx3cr1-Cre ERT2/+ mice were further crossed to A20 fl/wt eYFP +/+ mice to obtain eYFP-positive microglia upon recombination. All animal experiments were performed in accordance with the guidelines from the Central Animal Facility Institution. The mutations were induced at P14 and P16 (see below for treatment), and analyzed at 4 weeks of age, unless otherwise indicated.
METHOD DETAILS
Tamoxifen treatment A 20 mg/mL solution of tamoxifen (Sigma Aldrich) was prepared by suspension in olive oil (Sigma Aldrich) at 37 C for 2 hours on a shaker. Pups were injected subcutaneously with 2mg of tamoxifen, 2 days apart at P14 and P16.
BrdU treatment
On the same day as the first tamoxifen injection (at P18), mice were given 0.8 mg/mL of BrdU with 1% sucrose (w/v) in their drinking water over a period of 1 week. The water was changed once after 3 days. Mice were then left for an additional week after BrdU treatment, before being sacrificed at the 2 week time point after TAM injection, and brains collected for histology.
Organ isolation
Mice were deeply anesthetized by inhalation with isoflurane then transcardially perfused with 15-20mL NaCl before organs for analysis were removed. For histology: mice were perfused with ice-cold PBS and then with ice-cold 4% PFA. Brains were post-fixed in 4% PFA overnight and further processed for histology. For cell-isolation: Brain and spinal cord were digested using 1mg papain (for microglia analysis; Sigma-Aldrich) in HBSS with calcium and magnesium (Sigma-Aldrich) or Collagenase Type II (for microglia and lymphocyte analysis; GIBCO) for 30min at 37 C, before being passed through a 70mm cell strainer. CNS homogenates were put into a discontinuous 30%:70% percoll gradient and centrifuged without brakes. Myelin was discarded and the interface collected for further processing: either sorting of microglia for qPCR or sequencing; or flow cytometry analysis.
CD8 + T cell depletion CD8 cells were depleted in three-week-old mice with a depleting anti-CD8 antibody (kind gift from B. Ludewig, Switzerland). 300 mg anti-CD8 was injected i.p. every three days over 2 weeks. The deletion of A20 was induced with TAM two days after the first anti-CD8 injection and the second TAM injection administered two days later. Blood was taken from the tail before and 1 week after anti-CD8 injection and analyzed by flow cytometry to confirm CD8 + T cell depletion. Blood was collected with heparin to prevent clotting, and immune cells isolated with a Ficoll-gradient to remove the erythrocytes. Two weeks after the first tamoxifen injection mice were perfused with PBS, half of the brain was used for histological analysis of microglia and the other half was used for flow cytometry.
Flow cytometry staining: immune cell analysis
Single cell suspensions from the CNS were resuspended in FACS buffer (PBS with 2% FCS) with Fc-block for 20 minutes, washed and stained on ice for 20 min in the dark with a combination of the following stains or antibodies in FACS buffer: viability dye APC-eFl780 (1:1000; eBioscience); anti-CD45.2 FITC (1:1000; eBioscience); anti-CD11b PECy7 (1:1000; eBioscience); anti-TCRb biotin (1:200; BD Biosciences) and streptavidin PerCP (1:600; Biolegend).
